History of discovered and recommended antimicrobials and evolution of resistance in Neisseria gonorrhoeae, including the emergence of genetic resistance.

Slides:



Advertisements
Similar presentations
Khalil Ghanem, MD, PhD Associate Professor of Medicine Johns Hopkins University School of Medicine Director, STD/HIV/TB Clinical Services Baltimore City.
Advertisements

URETHRAL DISCHARGE Treat for Gonorrhoea and Chlamydia 4 Cs:
Update on Gonococcal Resistance in the United States Susan A. Wang, MD, MPH Division of STD Prevention National Center for HIV, STD, and TB Prevention.
Kingdom of Bahrain Ministry of Health ( Syndromic Mangement ) Adopted from : IPPF MEDICAL AND SERVICE DELIVERY GUIDELINES FOR SEXUAL AND REPRODUCTIVE HEALTH.
Antimicrobial Resistance in N. gonorrhoeae – An Overview 2014 INTRODUCTION Progressive antimicrobial resistance in Neisseria gonorrhoeae is an emerging.
Antimicrobial Resistance in N. gonorrhoeae: In Brief 2014 INTRODUCTION Increased action is needed to help prevent and control gonorrhea. Worldwide antimicrobial.
Antibiotics: Protein Synthesis, Nucleic Acid Synthesis and Metabolism.
Challenges to IPP: Emerging Gonococcal Antimicrobial Resistance and Skepticism That Screening in Its Current Form Can Reduce Chlamydial Morbidity Edward.
Antibiotics: Protein Synthesis, Nucleic Acid Synthesis and Metabolism.
Gonococcal Isolate Surveillance Project (GISP)
Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc. Chapter 94 Drug Therapy of Sexually Transmitted Diseases.
Antibiotic resistance in Neisseria gonorrhoeae
Sexually Transmitted Disease Surveillance 2011 Division of STD Prevention.
Sexually Transmitted Disease Surveillance 2013 Division of STD Prevention.
Denver Prevention Training Center Denver Public Health Department Pieces of the Puzzle Conference Great Falls November 21, 2013.
DRUGS USED FOR THE TREATMENT OF SYPHILIS & GONORRHEA.
Analysis of mutations within multiple genes associated with resistance in clinical isolate of Neisseria gonorrhoeae with reduced ceftriaxone susceptibility.
Is Gonorrhoea untreatable?
Trevor Winstanley Rebecca Clarke Department of Microbiology
Rapid Emergence of Gonococcal Fluoroquinolone Resistance in Men Who Have Sex with Men in King County, WA WLH Whittington MR Golden KK Winterscheid SA Wang.
DRUGS USED FOR THE TREATMENT OF SYPHILIS & GONORRHEA.
GONORRHEA Sexually Transmitted Disease Surveillance 2009 Division of STD Prevention.
South Dakota STD Update Webinar – August 15, 2012 Kees Rietmeijer, MD, PhD Medical Director, Denver STD/HIV Prevention Training Center.
FIGURE 1. URETHRAL DISCHARGE. Treatment of Urethral Discharge GonorrheaChlamydia Ciprofloxacin 500mg orally x 1 doseAzithromycin 1g orally x 1 dose Cefixime.
Neisseria gonorrhoeae Antimicrobial Resistance Robert D. Kirkcaldy, MD, MPH Division of STD Prevention NCHHSTP/CDC National Center for HIV/AIDS, Viral.
ANTIMICROBIAL AGINST B- LACTAMASE PRODUCERS 1)ANTISTAPH PENECILLINS e.g.CLOXACILLIN. 2)CEPHALOSPORINS. 3)CLINDAMYCIN. 4)CIPROFLOXACIN AND OTHER QUINOLONES.
Antimicrobial Resistance Surveillance (AMR Surveillance)
“High Percentages of Resistance to Tetracycline and Penicillin and Reduced Susceptibility to Azithromycin Characterize the Majority of Strain Types of.
Review of Gonorrhoea (GC) Contacts Gay Men’s Health Service 2012 / 2013 Louise PomeroyMick QuinlanSusan Clarke GMHSGMHSSJH / GMHS 9 th November 2013.
Tina McNutt. After this discussion the learner will be able to:  State the causative agent of the sexually transmitted infection (STI) gonorrhea  Explain.
Drug Therapy of Sexually Transmitted Diseases. Sexually Transmitted Diseases  Sexually transmitted diseases (STDs)  Infections or parasitic diseases.
BASHH Conference – Oxford 2016 Whole genome sequencing to predict Neisseria gonorrhoeae antibiotic susceptibility: toward tailored antimicrobial therapy.
A NEW RAPID RESAZURIN-BASED MICRODILUTION ASSAY FOR ANTIMICROBIAL SUSCEPTIBILITY TESTING OF NEISSERIA GONORRHOEAE Sunniva Förster 1,3,4, Valentino Desilvestro.
Should we fear antibiotic resistance for STIs?
Topic Gonorrhea Diseases
Lizzi Torrone, MSPH, PhD Lead, Surveillance & Special Studies Team
DRUGS USED FOR THE TREATMENT OF SYPHILIS & GONORRHEA
Gonococcal Isolate Surveillance Project (GISP)
Chlamydial and Gonococcal Infections
Gonorrhea Sexually Transmitted Disease Surveillance 2010
Nat. Rev. Urol. doi: /nrurol
In-Vitro activities of tetracyclines, macrolides, fluoroquinolones and clindamycin against Mycoplasma hominis and Ureaplasma ssp. isolated in Germany.
Empirical selection of an antibiotic in non-outbreak Vibrio cholerae infections in Nepal at the sub-health and health posts Patient Entry Available ATBs.
A decade of multi-drug resistant N. gonorrhoea in Coventry, UK
Neisseria gonorrhoeae: the first untreatable infection
Gonorrhoea antimicrobial resistance in Ireland, 2010 – 2017 On behalf of the National Forum on Antimicrobial Resistance in Neisseria gonorrhoeae Health.
Itraconazole tissue and fluid concentrations in humans as multiples of the maximal or simultaneously measured concentration in plasma (μg/ml) after systemic.
MIC distributions of selected β-lactam antimicrobial agents for H
In-Vitro activities of tetracyclines, macrolides, fluoroquinolones and clindamycin against Mycoplasma hominis and Ureaplasma ssp. isolated in Germany.
Approximate numbers of cases per 100,000 individuals caused by penicillin resistance for each year (left). Approximate numbers of cases per 100,000 individuals.
Median parasite counts during the first 40 days of patent parasitemia for 69 patients infected with Plasmodium malariae. Median parasite counts during.
Increasing prevalence of multidrug resistance among P
Number of outbreaks associated with drinking water by water system type and year (n = 780), 1971 to “Other” includes outbreaks associated with bottled.
Percentages of outbreak deficiencies (n = 671) in public water systems (n = 656) by time period, 1971 to 2006, excluding outbreaks associated with Legionella.
Potentiation of legacy antibiotics against P
Examples of antibiotic hybrid drugs that are active against Gram-negative pathogens: trimethoprim linked to ciprofloxacin–BP-4Q-002 (hybrid 5), the TyrRS.
Number of outbreaks associated with drinking water by system type and month (n = 762), 1971 to 2006, excluding outbreaks associated with commercially bottled.
Summary of the distribution and genetic context of the OXA-type enzymes in Acinetobacter baumannii. Summary of the distribution and genetic context of.
Fabrizio Dutly, and Martin Altwegg Clin. Microbiol. Rev. 2001; doi:10
Hector H. García et al. Clin. Microbiol. Rev. 2002; doi: /CMR
Roberta B. Carey et al. Clin. Microbiol. Rev. 2018; doi: /CMR
CDC-recommended regimens for intrapartum antibiotic prophylaxis for prevention of early-onset GBS disease. CDC-recommended regimens for intrapartum antibiotic.
Percentages of outbreak deficiencies in public water systems associated with untreated and improperly treated source water by year, 1971 to 2006, excluding.
Phylogenetic trees for fusion (F) and attachment (G) genes of selected HMPV isolates. Phylogenetic trees for fusion (F) and attachment (G) genes of selected.
Fluconazole zone diameter distributions for all Candida spp
Relationship between MIC, dose of fluconazole, and emergence/expression of specific resistance mechanisms in oropharyngeal candidiasis. •, MIC of fluconazole.
History of antibiotic discovery and concomitant development of antibiotic resistance. History of antibiotic discovery and concomitant development of antibiotic.
Schematic representation of the relationships between acid resistance (urease activity and urea transport), nitrogen metabolism (ammonia production), metal.
Example of population analysis profile curves for vancomycin-susceptible and heterogeneous vancomycin-intermediate S. aureus strains. Example of population.
Genetic events contributing to the evolution of Shigella spp
Presentation transcript:

History of discovered and recommended antimicrobials and evolution of resistance in Neisseria gonorrhoeae, including the emergence of genetic resistance determinants, internationally. History of discovered and recommended antimicrobials and evolution of resistance in Neisseria gonorrhoeae, including the emergence of genetic resistance determinants, internationally. During the preantimicrobial era (before the 1930s), treatment consisted of, e.g., a healthier lifestyle, copaiba, cubebs, urethral irrigations, potassium permanganate, silver compounds, mercury compounds, and hyperthermia. SUL, sulfonamides; PEN, penicillin; SPT, spectinomycin; TET, tetracycline; CIP, ciprofloxacin; OFX, ofloxacin; CFM, cefixime; CRO, ceftriaxone; AZM, azithromycin; DOX, doxycycline. Magnus Unemo, and William M. Shafer Clin. Microbiol. Rev. 2014; doi:10.1128/CMR.00010-14